18 November 2022

Discover Our New Fluorescent Ligands For Adrenergic Receptor

Our portfolio of #GPCR#fluorescent ligands is growingWe have just added to our catalogue two more fluorescent ligands for the α1-Adrenergic receptor, CELT-130 and CELT-133. α1-Adrenergic receptors play a vital role in the regulation of […]
9 November 2022

Celtarys Research, sponsor of the XIV Meeting of the Spanish Drug Discovery Network

The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Granada, Spain, on November 24 and 25, 2022. This international conference has […]
7 November 2022

New fluorescent tools to evaluate the therapeutic potential of phytocannabinoids

Cannabinoid receptors, CB1 and CB2 are two extensively studied targets of the GPCR family for the treatment of numerous conditions, including inflammatory diseases, autoimmune disorders, pain, […]
26 October 2022

Video webinar – Celtarys Colorectal Cancer & GPCR Fluorescent ligands

G-protein coupled receptors (GPCRs) have been targeted mainly in a wide range of diseases. Still, few therapies have been directed against GPCRs in the field of cancer, […]
20 September 2022

Fluorescent ligands: A New Method to Label your GPCRs

To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
26 July 2022

Celtarys Adenosine Receptor fluorescent ligands as potent tools for the study of cancer specific GPCRs

The ONCOMET group from the Health Research Institute of Santiago led by Dr. Miguel Abal has published an interesting article showing tumor and stromal-specific genetic signatures […]
15 July 2022

Celtarys Research and Chemspace sign a distribution agreement for the commercialization of Celtarys products

We are proud to announce our new collaboration with the marketplace company Chemspace for the distribution of our exclusive GPCR fluorescent probes. Chemspace is the largest […]
6 April 2022

New GLP1 Receptor fluorescent probes LUXendins developed by our collaborators Johannes Broichhagen and David J. Hodson

The glucagon-like peptide-1 receptor (GLP1R), expressed in peripheral tissues and brain, is known to be involved in several metabolic and inflammatory processes. Despite its clear interest […]
21 February 2022

Celtarys Research attends the SLAS meeting at Boston and is selected as finalist for the Ignite Award

From February 5th to 9th  our CEO Sonia Martínez Arca has attended the international SLAS,  (Society for Laboratory Automation and Screening), meeting at Boston.  Celtarys Research […]